Literature DB >> 3975343

Oro-facial granulomatosis--a clinical and pathological analysis.

D Wiesenfeld, M M Ferguson, D N Mitchell, D G MacDonald, C Scully, K Cochran, R I Russell.   

Abstract

A study of 60 patients with oro-facial granulomatosis has been conducted and the clinical presentation of this disorder defined. It encompasses the previously recognised clinical entities of Melkersson-Rosenthal syndrome and cheilitis granulomatosa. The pathological features of the disease are lymphoedema and the presence of multiple non-caseating giant cell granulomata. These granulomata are histologically indistinguishable from those found in both gastrointestinal Crohn's disease and systemic sarcoidosis. Within this series of patients, nine had evidence suggestive of gastrointestinal Crohn's disease, and in six this was confirmed. A diagnosis of sarcoidosis was made in a further two patients. The relationship of oro-facial granulomatosis to these systemic granulomatous diseases is not yet clear. Patients with oro-facial granulomatosis who have gastrointestinal symptoms should be investigated for the presence of gastrointestinal Crohn's disease. Those without symptoms should be investigated for evidence of malabsorption or serological evidence of Crohn's disease. Within the present study, the erythrocyte sedimentation rate, full blood count, corrected whole blood folate, serum albumin and calcium were the most sensitive markers of gastrointestinal involvement. Sarcoidosis should be considered in all patients with oro-facial granulomatosis. The absence of clinical signs suggestive of sarcoidosis, a normal chest radiograph and normal levels of serum angiotensin-converting enzyme makes sarcoidosis unlikely.

Entities:  

Mesh:

Year:  1985        PMID: 3975343

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  38 in total

1.  Elemental diet in the treatment of orofacial Crohn's disease.

Authors:  E A B Cameron; S J Middleton
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

2.  The perplexing case of the 11-year-old girl with a two year history of gingival swelling: clinical pathologic conference (IAOP/AAOMP meeting--San Francisco June 2008).

Authors:  Michael J Aldred; Sue-Ching Yeoh; Anna A Talacko; Anne K Gordon; Hedley G Coleman
Journal:  Head Neck Pathol       Date:  2008-09-06

3.  Anti-TNF-alpha therapy for orofacial granulomatosis: proceed with caution.

Authors:  D R Gaya; S Aitken; J Fennell; J Satsangi; A G Shand
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

4.  Molecular analysis of T cell receptor beta variability in a patient with orofacial granulomatosis.

Authors:  S H Lim; P Stephens; Q X Cao; S Coleman; D W Thomas
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

5.  Orofacial granulomatosis: a clinicopathologic correlation.

Authors:  Titus K Thomas; R S Neelakandan; Darpan Bhargava; Ashwini Deshpande
Journal:  Head Neck Pathol       Date:  2011-02-16

6.  Idiopathic orofacial granulomatosis - a diagnostic and treatment challenge.

Authors:  R Vishwanath Rangdhol; N Madhulika; A Dany; S Jeelani; G S Asokan
Journal:  J Clin Diagn Res       Date:  2014-11-20

7.  Strawberry gums: a clinicopathological manifestation diagnostic of Wegener's granulomatosis?

Authors:  S S Napier; J A Allen; C R Irwin; D R McCluskey
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

8.  The role of exclusive enteral nutrition in the management of orofacial granulomatosis in children.

Authors:  Mohamed Mutalib; Khaled Bezanti; Mamoun Elawad; Fevronia Kiparissi
Journal:  World J Pediatr       Date:  2016-11-03       Impact factor: 2.764

9.  Service evaluation of patients with orofacial granulomatosis and patients with oral Crohn's disease attending a paediatric oral medicine clinic.

Authors:  J L Howell; R M Bussell; A M Hegarty; H Zaitoun
Journal:  Eur Arch Paediatr Dent       Date:  2012-08

10.  Serum and salivary IgA antibody responses to Saccharomyces cerevisiae, Candida albicans and Streptococcus mutans in orofacial granulomatosis and Crohn's disease.

Authors:  N W Savage; K Barnard; P J Shirlaw; D Rahman; M Mistry; M P Escudier; J D Sanderson; S J Challacombe
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.